Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Founder and Chairman, Sycamore Networks
CEO of Zero Locus
Professor of Systems Biology, Columbia University
San Diego’s Biocom industry group is hosting this overview about the discovery, development, and regulatory processes for bringing a new drug to market. Participants will learn about the business and scientific decisions involved in moving a product forward from basic research into preclinical and clinical trials, as well as a detailed consideration of the regulatory requirements of clinical development. Post-approval commercial considerations and risk management will also be discussed. More information and online registration is here.